A carregar...
SCDT-39. NANOBIOCONJUGATES CROSSING BBB FOR DELIVERY OF CHECKPOINT INHIBITORS AND ACTIVATION OF LOCAL BRAIN TUMOR IMMUNE SYSTEMS FOR GLIOMA TREATMENT
Glioblastoma multiforme (GBM) still has limited treatment options. We introduce a new generation of nanobioconjugates that deliver anti-CTLA-4 and/or anti-PD-1 antibodies through blood-brain barrier (BBB) and activate local brain tumor immune response directed against GBM. METHODS: Immuno-nanobiocon...
Na minha lista:
Publicado no: | Neuro Oncol |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Oxford University Press
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691930/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.1120 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|